📌 Key Takeaways
- Topic: Sibelco Quartz: Product Range, Purity Grades and Applications
- Keywords: silicon oxide
- Published: 2026-11-20 08:30:50
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
What Is Silica Slurry? Composition, Types and Uses in Polishing
- Silica Bulk Density: Typical Values by Type and Why It Matters for Handling
- Zhao, R. et al. Constructing virus-like SiO x /CeO 2 /VO x nanozymes for 1064 nm light-triggered mild-temperature photothermal therapy and nanozyme catalytic therapy. Nanoscale 14, 361-372 (2022). Article CAS PubMed Google Scholar
- Electronic Grade Silica: Purity Requirements, Specifications and Applications
- Costa, J. A. S. et al. Synthesis, functionalization, and environmental application of silica-based mesoporous materials of the M41S and SBA-n families: a review. J. Environ. Chem. Eng. 9, 105259 (2021). Article CAS Google Scholar
- Silica Supplier Europe: Major Producers, Regulations and Sourcing Options
- Du, B. et al. Glomerular barrier behaves as an atomically precise bandpass filter in a sub-nanometre regime. Nat. Nanotechnol. 12, 1096-1102 (2017). Post CAS PubMed Central PubMed Google Scholar
- What Is Precipitated Silica? Production Process, Properties and Main Applications
- Mesoporous silica nanoparticles (MSNs) are recognized as a prime example of nanotechnology applied in the biomedical field, owing to their readily tunable structure and composition, various surface functionalization properties, and excellent biocompatibility. Over the past two decades, researchers have developed a wide range of MSNs-based nanoplatforms through careful design and controlled preparation approaches, demonstrating their adaptability to diverse biomedical application scenarios. With the continuous breakthroughs of MSNs in the fields of biosensing, disease diagnosis and treatment, tissue engineering, etc., MSNs are steadily moving from basic research to clinical trials. In this review, we supply a detailed summary of MSNs in the biomedical field, beginning with a comprehensive overview of their expansion history. We then discuss the types of MSNs-based nanostructured architectures, along with the classification of MSNs-based nanocomposites according to the elements existed in diverse inorganic functional factors. Subsequently, we summarize the primary purposes of surface-functionalized modifications of MSNs. In the following, we examine the biomedical applications of MSNs, and highlight the MSNs-based targeted therapeutic modalities currently developed. Given the importance of clinical translation, we also summarize the progress of MSNs in clinical trials. Lastly, we take a perspective on the future direction and remaining difficulties of MSNs in the biomedical field.
Talc Powder vs Silica: Differences and Which Filler to Choose
What is silica (SiO₂)?
semiconductor grade silica
What is the difference between fumed silica and precipitated silica?
silica supplier Yazdi, A. S. et al. Nanoparticles activate the NLR pyrin domain containing 3 (Nlrp3) inflammasome and cause pulmonary inflammation through release of IL-1α and IL-1β. Proc. Natl Acad. Sci. USA 107, 19449-19454 (2010). Article CAS PubMed Central PubMed Google Scholar
What drives silica raw material prices?
colloidal silica slurry MSNs-based scaffolds can enhance the cell proliferation, migration, adhesion and differentiation in bone tissue engineering. Many studies have systematically investigated and revealed the function of MSNs-based scaffolds in the regulation of cellular functions. 483, 484, 485, 486 Bone defects-involved regenerative mend is challenging to obtain a desired outcome due to the delay of early vascularization and poor osteogenic activity of bone implants. In this regard, researchers have designed a polycaprolactone network containing vascular-like structure, and introduced a nanofibrous gelatin-silica scaffold into it. Dimethyloxalylglycine (DMOG) and peptide-1 (BFP) were then loaded into MSNs, and the differential spatial distribution and sequential release of DMOG and BFP allowed the bioactive scaffold to promote angiogenesis by stimulating the migration of human umbilical vein endothelial cells (HUVECs), the tube formation and the expression of angiogenesis-related genes/proteins (HIF-1α, e-NOS, KDR and VEGF), as well as enhance osteogenesis by upregulating the expression of bone marrow-derived mesenchymal stem cells (BMSCs)-related osteogenic genes (Runx2, Col I, OPN and OCN) and promoting mineral matrix formation. 487 Apart from, Mora-Raimundo et al. reported MSNs as a nanocarrier to deliver SOST small interfering RNA (siRNA) and osteostatin, and the as-designed system could be used for osteoporosis remission via enhancing the bone microarchitecture. 379 Wang et al. designed a biomimetic silica-collagen scaffold via a robust biosilicification tactic, and the silica-collagen scaffold could mimic the distinctive microenvironment of bone extracellular matrix (ECM), resulting in the improvement of mesenchymal stem cell (MSC) recruitment and bone repair. 488 These MSNs-based scaffolds have excellent potential for clinical translation in the treatment of bone defects.
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.